A platform for leveraging next generation sequencing for routine microbiology and public health use by unknown
RESEARCH Open Access
A platform for leveraging next generation
sequencing for routine microbiology and public
health use
Laura I Rusu1*, Kelly L Wyres1, Matthias Reumann1, Carlos Queiroz1, Alexe Bojovschi1, Tom Conway1,
Saurabh Garg1, David J Edwards2, Geoff Hogg3, Kathryn E Holt2
From HISA Big Data in Biomedicine and Healthcare 2013 Conference
Melbourne, Australia. 18-19 April 2013
Abstract
Even with the advent of next-generation sequencing (NGS) technologies which have revolutionised the field of
bacterial genomics in recent years, a major barrier still exists to the implementation of NGS for routine
microbiological use (in public health and clinical microbiology laboratories). Such routine use would make a big
difference to investigations of pathogen transmission and prevention/control of (sometimes lethal) infections.
The inherent complexity and high frequency of data analyses on very large sets of bacterial DNA sequence data,
the ability to ensure data provenance and automatically track and log all analyses for audit purposes, the need for
quick and accurate results, together with an essential user-friendly interface for regular non-technical laboratory
staff, are all critical requirements for routine use in a public health setting. There are currently no systems to
answer positively to all these requirements, in an integrated manner.
In this paper, we describe a system for sequence analysis and interpretation that is highly automated and tackles
the issues raised earlier, and that is designed for use in diagnostic laboratories by healthcare workers with no
specialist bioinformatics knowledge.
Introduction
Despite the development of effective antimicrobial drugs
and anti-bacterial vaccinations, pathogenic bacteria con-
tinue to cause significant human morbidity and mortality
in all regions of the world [1-4]. The situation is exacer-
bated by the evolution and spread of antibiotic resistance,
a phenomenon identified as a major global health issue by
the World Health Organization [5]. In order to reduce the
burden of bacterial disease it is imperative that infections
are diagnosed and characterised in a timely manner, and
that the evolutionary and epidemiological dynamics of
bacterial populations are investigated. Microbiology diag-
nostic and public health laboratories play a primary role in
such tasks, and in this context bacterial genome sequence
analysis holds immense transformative potential [6,7].
Genomic sequences can be generated through the use of
next-generation sequencing (NGS) technologies, which
have been rapidly advancing in recent years. The applica-
tion of these technologies is revolutionising diagnostic and
public health microbiology due to the high yield and reso-
lution, low turn-around time and falling costs of the data
obtained [6,7]. Indeed there are already case studies that
demonstrate the feasibility of using NGS in this context e.
g. for high resolution investigation of hospital acquired
bacterial disease outbreaks or rapid estimation of bacterial
antimicrobial susceptibility [8,9]. In such cases information
derived from NGS data can rapidly inform clinical and
public health decisions, thereby improving infection con-
trol and patient outcomes.
The challenge in making NGS a reality for routine
diagnostic and public health laboratory use is that the
analysis is far from trivial, comprising multiple steps
(e.g. mapping or assembly of the genome, variant calling
and comparative phylogenetic analyses) [10]. Each step
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can be implemented using different tools and algo-
rithms, which may require case-by-case optimisation.
This process is time consuming and cumbersome since
most of the tools work in isolation and do not have a
user-friendly interface. Simple tools that would allow
healthcare professionals and laboratory staff to carry out
the analyses are not widely available, thus limiting the
analyses only to those with bioinformatics expertise
[7,8,11]. Further, the volume and variety of bacterial
genomes to be analysed present organisational and data
management challenges.
Next generation sequencing for microbiological
diagnostics
Microbiology laboratories may process hundreds of bac-
terial isolates each week [6]. Clinical laboratories receive
patient samples from which clinically-relevant bacteria
are cultured, purified and identified to an appropriate
taxonomic level [6,7]. In contrast, specialised public
health or reference laboratories receive pre-purified bac-
terial stocks. The scale and variety of bacterial isolates
encountered by such laboratories is exemplified by the
microbiology laboratory at the Oxford University Hospi-
tals Trust, UK, where 751,134 isolates were cultured over
a 15 year period (i.e. approximately 960 isolates per
week). Seventy-four percent of these isolates were classi-
fied to the species level and represented a total of 301
different species [6].
Identification may be followed by further characterisa-
tion, whereby the required spectrum of tests is dependent
upon the bacterial species or clinical situation in ques-
tion. Such tests, for which the specific protocols also vary
in a species-dependent manner, include antibiotic sus-
ceptibility testing, epidemiological typing, toxin and viru-
lence gene screening. The necessary laboratory
techniques may include microscopy, susceptibility testing
by disc diffusion or E-test, biochemical assay, polymerase
chain reaction and capilliary sequencing. As such, full
bacterial characterisation may require several days or
even weeks for completion [6,7].
In contrast to traditional methods, NGS data represent-
ing almost an entire bacterial genome can be generated
in a matter of hours, independent of species classification
[12,13]. These data can provide much of the information
required for bacterial characterisation and/or compari-
son, including epidemiological typing [14,15], antibiotic-
resistance, toxin and virulence gene information
[14,16,17]. Furthermore, NGS data provide information
at a much higher resolution than that of traditional tech-
niques, allowing fine-scale epidemiological investigations.
Such enhanced resolution has already been shown to
facilitate improved detection of pathogen transmission
and outbreak foci [8,18,19]. In particular, an investigation
of a set of meticillin-resistant Staphylococcus aureus
infections in a British hospital identified a staff member
as the focal point of transmission and led to the formula-
tion of an appropriate intervention strategy. Crucially, it
was shown that these findings could not be determined
by the use of traditional characterisation techniques
alone [8].
Unfortunately given that microbiology laboratory staff
should not be expected to possess advanced bioinfor-
matics skills, the lack of automated and user-friendly
NGS analysis tools is a major barrier to the routine use
of NGS technologies in public health and diagnostic
laboratories [7,8]. There are also difficulties relating to
the management of large/variable data sets and analysis
record-keeping, both of which are essential if meaningful,
accurate and reliable conclusions are to be drawn from
the data.
Related works
Over recent years, there have been several commercial
and open source initiatives that integrate specific NGS
analysis components (e.g. Pipeline Pilot [20], Taverna
[21] and Galaxy [22]). These systems provide interfaces
to create and run analysis pipelines using different NGS
analysis tools (e.g. BWA [23], SamTools [24] and
MAUVE [25]). Some of the benefits offered by these
systems are accessibility (providing a user interface for
running and creating NGS analysis pipelines), reproduci-
bility (one can save the analysis and metadata associated
with it), transparency (one can share and publish analy-
sis pipelines), and the ability to integrate new tools.
Most of these features satisfy the needs of a researcher
with bioinformatics skills. However, they are not suffi-
cient for routine use within microbiological diagnostics
and public health laboratories. In particular, these sys-
tems lack enterprise setting capabilities, such as data
management of large and variable datasets, auditing,
governance and access control/security functionalities
sufficient for multiple users with different responsibil-
ities. As such these systems have not been employed in
the laboratory setting.
In this paper, we propose a sequence analysis and
interpretation system which is highly automated and
that tackles the issues raised earlier. It is designed for
use in diagnostic laboratories by healthcare workers
with no specialist IT or bioinformatics knowledge.
The next section provides a high level description of
the proposed system, followed by the description of a
use case showing how the system would respond to a
number of routine NGS analysis tasks performed by a
biologist employed in a generic microbiology laboratory.
Proposed system description
The architectural framework of the system consists of
four layers (illustrated in Figure 1) where the focus is on
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usability and where the computation is completely hidden
from users, i.e. users do not need to specify or understand
what computational resources should be used to carry out
the analyses.
The User Interface (UI) Layer allows the user to
upload data as required (sequence data files, isolate meta-
data, reference data etc.) and perform various searches.
The user is also able to create, modify and run analyses
by specifying the required input data and applicable para-
meters. The tool also allows creation and management of
NGS analysis workflows in a visual (drag and drop) man-
ner. A user can connect various analysis modules using
arrows, thereby creating the analysis workflow. In addi-
tion to analysis modules (e.g. BWA), a workflow can
include visualisation modules. If required, the user has
the ability to run the same analysis workflow with differ-
ent parameter sets, in parallel (e.g. to compare results),
or run totally different analysis workflows at the same
time. Reports can also be produced to detail or visualise
results of any given analysis.
The Web APIs (Application Programing Interfaces)
layer is the link between the UI and the Middle Layer.
For example, once the user sets up and starts an analysis,
the applicable workflow description and requirements
are passed to the Middle Layer via an API. By having a
standard set of APIs that are exchanged in a standard for-
mat [27], the actual implementation of the UI (e.g. web
client, phone application) is independent from any speci-
fic implementation of the Middle Layer.
The Middle Layer provides a runtime environment to
execute the analysis workflows. Each request received
from the UI layer (e.g. a search for isolates, a new analysis
run etc.) is coordinated by the Middle Layer and passed
to the Physical Layer as required. For example, when a
new analysis workflow definition is received from the UI,
it is loaded and interpreted by the Middle Layer, and the
required analysis modules are passed to the Physical
Layer to be scheduled and executed in the appropriate
order. If requested in the workflow definition, the Middle
Layer also facilitates passing of the results for each mod-
ule run, from the Physical Layer back to the UI Layer, to
be visualised. The Middle Layer also ensures a solid file
management and data provenance practice, by linking
the information about each module of an analysis, the
associated input files, parameters and results with any
intermediate or output files.
Figure 1 Proposed analysis framework for whole genome sequencing analysis in diagnostic microbiology.
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The Physical Layer has two major roles: one is to store
all the relevant data in the system (e.g. isolate metadata,
sequence data files, reference metadata/files), together
with workflow definitions and analysis results, in a data-
base which is linked to a file management system. The
other major role is to take care of scheduling and running
the requests received from the Middle Layer. The Physical
Layer also assesses the computational requirements for
each request and allocates resources for parallel comput-
ing if required for a particular task (e.g. allocate a very
intensive analysis task to be run on a computer cluster
(local or remote) or a supercomputer).
Use case example
Here we describe a hypothetical analysis flow which could
be performed by a biologist in a generic microbiology
laboratory on a regular basis (see Figure 2 for a visual
representation of the hypothetical analysis flow). For each
major step in the flow we show how the user interacts
with the system and what actions would be taken in order
to fulfil the analysis requirements:
The microbiology laboratory has received a set of
Listeria monocytogenes isolates and a set of Salmo-
nella enterica serovar Typhi isolates for characterisa-
tion. The isolates have been cultured, their DNA
extracted and sequenced on the Illumina MiSeq
platform. The laboratory protocols dictate that a
multi-locus sequence typing (MLST [28]) analysis
should be completed for all isolates, whilst an anti-
biotic resistance gene analysis should be completed
for the S. enterica ser. Typhi isolates only. Informa-
tion about the isolates (including the laboratory iso-
late identifier, species, date of collection and date of
receipt by the diagnostic laboratory) is available in a
spreadsheet and uploaded into the system by a
laboratory staff member.
System access: Upload Isolate Data;
User Actions: Select one or more isolate data
file; upload and review success or errors; edit
records and re-upload as needed;
The corresponding sequence data files (in Fastq for-
mat) are also uploaded and automatically linked by
the system to the correct isolate records.
System access: Upload Sequence Data;
User actions: Select a folder or a subset of Fastq
files; provide sequencing run details; validate the
automated system matching of sequence files
with the isolate data;
Firstly, the laboratory staff member would like to con-
duct the MLST analyses; he/she can use the isolate
search functionality to identify all L. monocytogenes
isolates in the isolate database for which an MLST
analysis has not yet been completed. The “Select All”
feature can be used to select all of the identified iso-
lates for inclusion in an MLST analysis run.
System access: Search Isolates;
User actions: Specify search criteria as needed;
select one, some or all isolate records;
The staff member can then navigate to the “Create
New Analysis” screen, select the MLST analysis
type and confirm the parameter values to be used (the
appropriate values are set as default, see below for
more details). The appropriate species-specific MLST
reference database is automatically selected by the sys-
tem based upon the species designation of the nomi-
nated isolates. The raw sequence data files upon which
the analysis is to be performed are also selected auto-
matically by the system, using the isolate metadata -
sequence data link information. Thus there is no need
for the laboratory staff member to manually search for
and identify isolates to be included in the analysis, nor
is there a need for the staff member to manually
locate, copy or move the appropriate raw sequence
data files. The laboratory staff member can start the
MLST analysis simply by clicking the “Start” button.
There is no need for the staff member to select a spe-
cific analysis algorithm since the system stores and uti-
lises a list of default ‘preferred’ algorithms (see below
for more details, e.g. SRST [29] for MLST analysis).
There is no need for the staff member to allocate spe-
cific compute resources or provide information about
the memory or wall-time requirements for the analysis
job. The system will handle all such requirements and
make appropriate decisions.
System access: Create New Analysis;
User actions: Specify species of isolates; specify
type of analysis; select isolate records to be used;
specify reference file; specify other parameters as
applicable; start analysis;
Whilst the L. monocytogenes analysis is running, the
staff member can also set-up and start both an MLST
analysis and an antibiotic resistance gene analysis for
the S. enterica ser. Typhi isolates. The staff member
can use the list of recent analyses or the analysis search
tool to monitor the progress of their analyses.
System access: Open most recent analyses or
Search Analyses;
User actions: Specify search criteria; select one,
some or all analyses; view analyses details & status;
stop/start analyses; pause/resume analyses;
Upon completion, the results of the analyses are auto-
matically linked to the appropriate isolate metadata
records in the isolate database. The staff member would
like to compare the results of their L. monocytogenes
MLST analysis with those completed for all L. monocyto-
genes isolates received by the laboratory within the last
year; he/she can use the isolate search feature to find all
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of the relevant isolate metadata records, and subse-
quently view changes in the distribution and frequency
of clonal group (groups of ancestrally closely related iso-
lates defined by MLST data comparisons) representa-
tives through time.
System access: Search Isolates;
User actions: Specify search criteria as needed;
select one, some or all isolate records; view and
compare analyses results;
This comparison indicates that there has been a
recent increase in the number of isolates representing
ST13 (multi-locus sequence type 13) and its closely
Figure 2 Diagrammatic representation of the hypothetical workflow described in the use case.
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related variants. Such a change in the frequency and
distribution of clonal groups may indicate a local
L. monocytogenes outbreak. In order to confirm the
relatedness of the suspected outbreak isolates in com-
parison to other L. monocytogenes isolates represent-
ing the same or closely related STs, the staff member
can use the isolate search feature to identify and
select all closely related L. monocytogenes isolates for
which sequence data is available.
The genomes of these isolates can be further investi-
gated, e.g. by construction of a phylogeny through
reference-based sequence mapping and variant call-
ing across the wider L. monocytogenes genome.
Unlike the MLST analysis, which can be completed by
the use of a single tool, this type of analysis requires a
multi-module process including read-mapping to a
reference sequence (e.g. using BWA [23]), variant call-
ing (e.g. using SAMTools [24]), phylogeny construc-
tion (e.g. using RAxML [30]) and quality filtering (e.g.
to trim or filter sequence reads below a quality thresh-
old, or to apply a minimum read mapping depth, per-
centage read concordance and/or minimum base
quality threshold for variant calls). However, the
laboratory staff member is able to select and use such
workflows in the single step. In this case the staff
member will simply need to identify and select the iso-
lates for inclusion and an appropriate reference gen-
ome from within the reference database, plus confirm
the analysis parameters (e.g. use the default specifica-
tion or an alternate choice). For example, the staff
member may wish to change the minimum read depth
or base quality for variant calls.
As above, the staff member does not need to think
about the specific analysis tools that are required,
since the default ‘preferred’ tools will be automatically
selected by the system. Such tool (and parameter)
preferences can be customised by the system admin-
istrator based on the current best-practice recom-
mendations and laboratory preferences. However,
users with the right knowledge and inclination do
have the option to select alternative analysis tools for
one or all of the analysis modules in the workflow.
System access: Search References;
User actions: Specify search criteria as needed;
select the applicable reference files;
As it can be seen in the above example, the actions
which a non-bioinformatics laboratory user must take in
order to fulfil his/her analysis task requirements using
the system are quite simple. The system automates as
much of the process as possible thereby reducing manual
interaction of the user with the data and the potential
impact of human error. For example, the sequence data
is automatically linked to the correct isolate metadata
records, the appropriate species-specific reference file
and the raw data files are selected automatically by the
system when the user creates a new analysis run. Addi-
tionally, the results of the analyses are automatically
linked to the appropriate isolate metadata records and
analysis record details. Moreover, all computation related
information is completely hidden from the user (e.g. the
specific modules that were run, in which order, on which
computer/cluster, how much memory and compute
resources were required, etc.).
Conclusions
Our aim is to facilitate the routine use of NGS technol-
ogies in diagnostic and public health microbiology
laboratories. In this paper we described a system which
is user-friendly, flexible and scalable, and which could
be used by regular laboratory staff members, without
specific bioinformatics training. This system overcomes
the difficulties met by existing approaches, in regards to
usability, scale and variety of genomic data which could
be processed, data management, automation of required
tasks, as well as auditing capabilities which are critical
for any system in the public health sector.
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